File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.xphs.2026.104156
- Find via

Supplementary
-
Citations:
- Appears in Collections:
Article: Overcoming translational barriers in nose-to-brain drug delivery for clinical applications
| Title | Overcoming translational barriers in nose-to-brain drug delivery for clinical applications |
|---|---|
| Authors | |
| Issue Date | 8-Jan-2026 |
| Publisher | Elsevier |
| Citation | Journal of Pharmaceutical Sciences, 2026 How to Cite? |
| Abstract | Social service nonprofits (SSNs) are often subject to institutional pressures to gain legitimacy and credibility from the government. While previous research has explored nonprofits' strategic responses and the factors that shape organizational behaviors in response to government regulations, little is known about how SSNs strategize to respond in non-Western contexts where civil society is comparatively restricted. Drawing on 21 in-depth interviews with nonprofit managers in Shanghai, China, we examined the strategic responses employed by SSNs to manage and navigate the government-sponsored accreditation system, an evaluation process that rates nonprofits' performance from 1A to 5A. Findings identify three strategic responses: pursuing, compromising, and avoiding, shaped by organizational (evaluation capacity, political connections) and field-level (isomorphic sector development, enforcement barriers) factors. These findings suggest that SSNs balance compliance and autonomy by building internal capacity and establishing political ties to secure legitimacy, while mitigating the costs of state-imposed evaluation. This study offers new insights into nonprofit strategic management in restrictive institutional environments. |
| Persistent Identifier | http://hdl.handle.net/10722/368571 |
| ISSN | 2023 Impact Factor: 3.7 2023 SCImago Journal Rankings: 0.705 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zhang, Xinyue | - |
| dc.contributor.author | Chow, Stephanie | - |
| dc.contributor.author | Chan, Ho Wan | - |
| dc.contributor.author | Chow, Shing Fung | - |
| dc.date.accessioned | 2026-01-14T00:35:28Z | - |
| dc.date.available | 2026-01-14T00:35:28Z | - |
| dc.date.issued | 2026-01-08 | - |
| dc.identifier.citation | Journal of Pharmaceutical Sciences, 2026 | - |
| dc.identifier.issn | 0022-3549 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/368571 | - |
| dc.description.abstract | <p>Social service nonprofits (SSNs) are often subject to institutional pressures to gain legitimacy and credibility from the government. While previous research has explored nonprofits' strategic responses and the factors that shape organizational behaviors in response to government regulations, little is known about how SSNs strategize to respond in non-Western contexts where civil society is comparatively restricted. Drawing on 21 in-depth interviews with nonprofit managers in Shanghai, China, we examined the strategic responses employed by SSNs to manage and navigate the government-sponsored accreditation system, an evaluation process that rates nonprofits' performance from 1A to 5A. Findings identify three strategic responses: <em>pursuing, compromising,</em> and <em>avoiding</em>, shaped by organizational (evaluation capacity, political connections) and field-level (isomorphic sector development, enforcement barriers) factors. These findings suggest that SSNs balance compliance and autonomy by building internal capacity and establishing political ties to secure legitimacy, while mitigating the costs of state-imposed evaluation. This study offers new insights into nonprofit strategic management in restrictive institutional environments.<br></p> | - |
| dc.language | eng | - |
| dc.publisher | Elsevier | - |
| dc.relation.ispartof | Journal of Pharmaceutical Sciences | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.title | Overcoming translational barriers in nose-to-brain drug delivery for clinical applications | - |
| dc.type | Article | - |
| dc.description.nature | published_or_final_version | - |
| dc.identifier.doi | 10.1016/j.xphs.2026.104156 | - |
| dc.identifier.eissn | 1520-6017 | - |
| dc.identifier.issnl | 0022-3549 | - |
